Aspen Neuroscience

About

Aspen Neuroscience is a biotechnology company that specializes in personalized cell therapies.

San Diego,California,United States
51 - 100
https://www.aspenneuroscience.com

Highlights

Details

Last Funding Type: Debt Financing
Last Funding Money Raised: $40M
Industries: Biotechnology,Medical,Pharmaceutical,Therapeutics
Founded date: Jan 1, 2018
Number Of Employee: 51 - 100
Operating Status: Active
Legal Name: Aspen Neuroscience, Inc.

Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

4

$264M

Aspen Neuroscience has raised a total of $264M in funding over 2 rounds. Their latest funding was raised on Dec 21, 2022 from a Debt Financing round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Dec 21, 2022	Debt Financing	$40M	1	Silicon Valley Bank	—	Detail
May 9, 2022	Series B	$147.50M	15	GV LYFE Capital Revelation Partners	—	Detail
Apr 1, 2020	Series A	$70M	6	OrbiMed	—	Detail
Dec 12, 2019	Seed	$6.50M	6	Domain Associates	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

2

Aspen Neuroscience has made 3 investments. Their most recent investment was on Mar 15, 2022, when BlueStone raised $30M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Mar 15, 2022 BlueStone	Series Unknown	$30M	E-Commerce	Yes
Jun 2, 2020 Nykaa	Series H	$2.60M	Beauty	Yes
May 14, 2018 Nykaa	Series D	₹1.65B	Beauty	—

Investors

Number of Lead Investors

Number of Investors

6

20

Aspen Neuroscience is funded by 20 investors. Silicon Valley Bank and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Silicon Valley Bank	Yes	Debt Financing
GV	Yes	Series B
LYFE Capital	Yes	Series B
Revelation Partners	Yes	Series B
Alexandria Venture Investments	—	Series B
ARCH Venture Partners	—	Series B
Bioverge	—	Series B
EDBI	—	Series B
Frazier Life Sciences	—	Series B
Lifeforce Capital	—	Series B